Please note that T. Rowe Price actually owns (as of 12/31/12) 13.1 million shares and warrants to purchase an additional 7.9 million shares making them the ***beneficial owner***** of 21 million shares.
Hey Bigfella, any examples of other biotech success stories where T Rowe lead the charge? The news sounds great to me, but I am a bit green on the biotech investment stuff and am not sure where the institutional investors fit into the picture in both the long and short term. Any other folks have examples of other T Rowe favorites?
i know they had over 7 million shares of YMI. cant think of an others right off hand. we have a long list of heavy hitters who own cytk. i am looking forward to friday so we can see all the new filings